Where does Claire Brown work?

Claire Brown is Partner at Oxford Science Enterprises.

What does Claire Brown invest in?

Claire Brown invests in Biotech.

What check size does Claire Brown write?

Claire Brown typically writes checks of $100K – $5M.

Where did Claire Brown go to school?

Claire Brown studied at University of Glasgow (BSc (Hons), Physiology); Glasgow Caledonian University (Ph.D, Pharmacology); Loughborough University (MBA, Business Administration and Management).

Claire Brown

Investor

Partner at Oxford Science Enterprises

Oxford, United Kingdom

Writes $100K – $5M checks · typically $1.5M

About

Claire Brown has over 20 years of biopharmaceutical experience across the UK and US, spanning R&D strategy, licensing, business development and corporate investment. At OSE she leads company creation and portfolio strategy in Life Sciences, having joined in 2020 after roles at UCB, Sanofi-Genzyme, AstraZeneca and as Head of Investment at Pioneer Group.

Contact· self-published, not guessed

c•••@oxfordsciences.comreveal

Invests in

Biotech

Experience

Oxford Science EnterprisesPartnercurrent2020 — presentOxford, England, United Kingdom
Acionna TherapeuticsBoard of Directorscurrent2025 — present
Scripta TherapeuticsBoard of Directorscurrent2025 — present
Thelior BioBoard Directorcurrent2025 — present
T-Cypher BioBoard Directorcurrent2021 — presentOxford, England, United Kingdom
AlveoGeneBoard Directorcurrent2023 — present
Orfonyx BioBoard Directorcurrent2022 — present
Nucleome TherapeuticsBoard Observercurrent2023 — present
OMass TherapeuticsBoard Observer2021 — 2024
Dark Blue TherapeuticsBoard Director2020 — 2023Oxford, England, United Kingdom
AlethiomicsBoard Director2022 — 2023
Kinomica LimitedBoard Of Directors2019 — 2021London and Manchester, UK
Pioneer GroupHead of Investment2015 — 2021Alderley Park
NanoSyrinxBoard of Directors2020Warwick, England, United Kingdom
Rinri Therapeutics Ltd.Board Of Directors2019 — 2020Sheffield, UK
AstraZenecaDirector, Strategy, Business Development and Investment2007 — 2015UK
Sanofi GenzymePrincipal Scientist, Pharmacology & Toxicology2004 — 2007USA
UCB Research IncPharmacology Dept, Principal Scientist2000 — 2004

Skills & more

Drug Development9Life Sciences23Biotechnology21Drug Discovery15Pharmacology7R&D16

Investment Management Certificate — CFA Institute
Role of the Board — Institute of Directors (IoD)

From Claire's professional profile.

Colleagues at Oxford Science Enterprises

Alex Hammacher

Head of Strategic Operations & Corporate Finance at Oxford Science Enterprises

Alexandra Riozzi

Executive Assistant at Oxford Science Enterprises

Alicia Mederick

Team Co-ordinator at Oxford Science Enterprises

Alma Simangunsong

People Apprentice at Oxford Science Enterprises

Andre Crawford-Brunt

Non-Executive Director at Oxford Science Enterprises

Andrew Straiton

Senior Associate, Deep Tech at Oxford Science Enterprises

Andy Penfold

Content Lead at Oxford Science Enterprises

Antonia Jenkinson

Chief Financial Officer at Oxford Science Enterprises

Network3

Lilly Bussmann

Partner at Oxford Science Enterprises

Martin Fiennes

Advisor, Deep Tech at Oxford Science Enterprises

Nicholas Dixon-Clegg

Partner, Head of Independent Investments at Oxford Science Enterprises

Investors connected to Claire in public investor directories — a warm-intro map.

Frequently asked questions

Who is Claire Brown?: Claire Brown has over 20 years of biopharmaceutical experience across the UK and US, spanning R&D strategy, licensing, business development and corporate investment. At OSE she leads company creation and portfolio strategy in Life Sciences, having joined in 2020 after roles at UCB, Sanofi-Genzyme, AstraZeneca and as Head of Investment at Pioneer Group.
Where does Claire Brown work?: Claire Brown is Partner at Oxford Science Enterprises.
What does Claire Brown invest in?: Claire Brown invests in Biotech.
What check size does Claire Brown write?: Claire Brown typically writes checks of $100K – $5M.
Where did Claire Brown go to school?: Claire Brown studied at University of Glasgow (BSc (Hons), Physiology); Glasgow Caledonian University (Ph.D, Pharmacology); Loughborough University (MBA, Business Administration and Management).

Same school

Also attended University of Glasgow92

Andreas SchropferHead of Finance at Brighteye Ventures Sarah MandersonLegal Director at Hoxton Ventures Kelsey BolanderAssociate — Business Ops & Partner Support at Energize Ventures Rob DesboroughGeneral Partner and Chair of Seraphim Space Accelerator at Seraphim Space Aida KhalilProgramme Associate at Seraphim Space Natalie JohnstonInvestment Principal at 4BIO Capital

+ 86 more

Also attended Glasgow Caledonian University13

Costanza CariniInvestor at DN Capital Mike SapnarHead of Insurance Solutions & CEO of Longtail Re at Stone Ridge Asset Management Kerry SharpChief Finance & Investment Officer at Scottish Venture Fund Kerry SharpChief Finance & Investment Officer at Scottish Enterprise Imogen PohlFront of house at Bowmark Capital Phemelo MabuseResearch Analyst at Injini

+ 7 more

Also attended Loughborough University77

Abbie RobusAssociate Director at Mayfair Equity Partners Diane WalkerHead of Group Finance & Operations at Mayfair Equity Partners Costanza CariniInvestor at DN Capital Joe HalliwellClient Team Member at Generation Investment Management Alasdair MitchellPortfolio Support at Giant Ventures Global Llp George CadburyPartner at GVP Climate

+ 71 more

Also attended CFA Institute309

Matt CherianVenture Partner at Monta Vista Capital Laviva MazharPrincipal at Luge Capital Jan AvontsInvestment Director at Capricorn Venture Partners Kim RobertsonFinancial Manager at 4Di Capital Cole LundquistPrincipal at QED Investors Andreas GallikerChief Financial Officer at Mercury Fund

+ 303 more

Shared employers

+ 64 more